152 related articles for article (PubMed ID: 30265311)
1. Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
Ben-Shachar S; Finezilber Y; Elad H; Rabinowitz K; Goren I; Isakov O; Yanai H; Dotan I
Inflamm Bowel Dis; 2019 Jan; 25(2):336-344. PubMed ID: 30265311
[TBL] [Abstract][Full Text] [Related]
2. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.
Lakatos PL; Altorjay I; Szamosi T; Palatka K; Vitalis Z; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Barta Z; Stocker W; Papp J; Veres G; Papp M;
Inflamm Bowel Dis; 2009 Mar; 15(3):365-74. PubMed ID: 18972554
[TBL] [Abstract][Full Text] [Related]
4. Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.
Goren I; Godny L; Reshef L; Yanai H; Gophna U; Tulchinsky H; Dotan I
Inflamm Bowel Dis; 2019 Mar; 25(4):742-749. PubMed ID: 30535148
[TBL] [Abstract][Full Text] [Related]
5. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.
Murdoch TB; Xu W; Stempak JM; Landers C; Targan SR; Rotter JI; Silverberg MS
Inflamm Bowel Dis; 2012 Sep; 18(9):1743-8. PubMed ID: 22275320
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
[TBL] [Abstract][Full Text] [Related]
7. Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels.
Vasseur F; Sendid B; Jouault T; Standaert-Vitse A; Dubuquoy L; Francois N; Gower-Rousseau C; Desreumaux P; Broly F; Vermeire S; Colombel JF; Poulain D
Inflamm Bowel Dis; 2012 Mar; 18(3):430-8. PubMed ID: 21739538
[TBL] [Abstract][Full Text] [Related]
8. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
[TBL] [Abstract][Full Text] [Related]
9. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
Goren I; Yahav L; Tulchinsky H; Dotan I
Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
[TBL] [Abstract][Full Text] [Related]
10. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
[TBL] [Abstract][Full Text] [Related]
11. [Relevance of serologic studies in inflammatory bowel diseases].
Papp M; Altorjay I; Lakatos PL
Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
[TBL] [Abstract][Full Text] [Related]
12. NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.
Dassopoulos T; Nguyen GC; Talor MV; Datta LW; Isaacs KL; Lewis JD; Gold MS; Valentine JF; Smoot DT; Harris ML; Oliva-Hemker M; Bayless TM; ; Burek CL; Brant SR
Am J Gastroenterol; 2010 Feb; 105(2):378-86. PubMed ID: 19826411
[TBL] [Abstract][Full Text] [Related]
13. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.
Heliö T; Halme L; Lappalainen M; Fodstad H; Paavola-Sakki P; Turunen U; Färkkilä M; Krusius T; Kontula K
Gut; 2003 Apr; 52(4):558-62. PubMed ID: 12631669
[TBL] [Abstract][Full Text] [Related]
14. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
15. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.
Halfvarson J; Standaert-Vitse A; Järnerot G; Sendid B; Jouault T; Bodin L; Duhamel A; Colombel JF; Tysk C; Poulain D
Gut; 2005 Sep; 54(9):1237-43. PubMed ID: 15863472
[TBL] [Abstract][Full Text] [Related]
16. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
[TBL] [Abstract][Full Text] [Related]
17. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population.
Marrakchi R; Bougatef K; Moussa A; Ouerhani S; Khodjet-el-Khil H; Messai Y; Mestiri O; Najar T; Benammar-Elgaaeid A
Inflamm Res; 2009 Apr; 58(4):218-23. PubMed ID: 19184350
[TBL] [Abstract][Full Text] [Related]
18. Antiglycan antibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Drygiannakis D; Tsirogianni A; Oustamanolakis P; Karmiris K; Papamichael K; Mantzaris GJ; Kouroumalis EA
Dig Dis Sci; 2011 Mar; 56(3):845-52. PubMed ID: 20632100
[TBL] [Abstract][Full Text] [Related]
19. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.
Frank DN; Robertson CE; Hamm CM; Kpadeh Z; Zhang T; Chen H; Zhu W; Sartor RB; Boedeker EC; Harpaz N; Pace NR; Li E
Inflamm Bowel Dis; 2011 Jan; 17(1):179-84. PubMed ID: 20839241
[TBL] [Abstract][Full Text] [Related]
20. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
